These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5652 related articles for article (PubMed ID: 3349667)

  • 1. Antimetastatic action of orally administered lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Perissin L; Zorzet S
    Clin Exp Metastasis; 1988; 6(3):245-53. PubMed ID: 3349667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of B16 melanoma metastases by oral administration of egg-white lysozyme.
    Sava G
    Cancer Chemother Pharmacol; 1989; 25(3):221-2. PubMed ID: 2598413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the antineoplastic action of lysozyme: evidence for host mediated effects.
    Sava G; Ceschia V; Pacor S
    Anticancer Res; 1989; 9(4):1175-80. PubMed ID: 2817798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma.
    Sava G; Ceschia V; Pacor S; Zabucchi G
    Anticancer Res; 1991; 11(3):1109-13. PubMed ID: 1888145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic effects of egg-white lysozyme in mice bearing solid metastasizing tumors.
    Sava G; Perissin L; Zorzet S; Callerio C
    Anticancer Res; 1986; 6(2):183-6. PubMed ID: 3707053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride.
    Sava G; Pacor S; Nardon E; Dobrina A
    J Chemother; 1992 Aug; 4(4):228-34. PubMed ID: 1403079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties.
    Sava G; Pacor S; Mestroni G; Alessio E
    Clin Exp Metastasis; 1992 Jul; 10(4):273-80. PubMed ID: 1617835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma.
    Pacor S; Giacomello E; Bergamo A; Clerici K; Zacchigna M; Boccu E; Sava G
    Anticancer Res; 1996; 16(5A):2559-64. PubMed ID: 8917351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for host-mediated antitumor effects of lysozyme in mice bearing the MCa mammary carcinoma.
    Sava G; Ceschia V; Zabucchi G
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1737-43. PubMed ID: 3208816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse.
    Sava G; Ceschia V; Pacor S; Zorzet S; Perissin L
    Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):683-9. PubMed ID: 2622298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimetastatic effect of an orally active heparin derivative on experimentally induced metastasis.
    Lee DY; Park K; Kim SK; Park RW; Kwon IC; Kim SY; Byun Y
    Clin Cancer Res; 2008 May; 14(9):2841-9. PubMed ID: 18451252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
    Merriman RL; Shackelford KA; Tanzer LR; Campbell JB; Bemis KG; Matsumoto K
    Cancer Res; 1989 Aug; 49(16):4509-16. PubMed ID: 2743339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor and antimetastatic effects of benzenoid triazenes in mice bearing Lewis lung carcinoma.
    Giraldi T; Guarino AM; Nisi C; Sava G
    Pharmacol Res Commun; 1980 Jan; 12(1):1-11. PubMed ID: 7384159
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon-alpha improves docetaxel antitumoral and antimetastatic efficiency in Lewis lung carcinoma bearing mice.
    Ben Reguiga M; Bouquet C; Farinotti R; Bonhomme-Faivre L
    Life Sci; 2012 Oct; 91(17-18):843-51. PubMed ID: 23047021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetastatic and growth-inhibitory effects of N-acetylchitohexaose in mice bearing Lewis lung carcinoma.
    Tsukada K; Matsumoto T; Aizawa K; Tokoro A; Naruse R; Suzuki S; Suzuki M
    Jpn J Cancer Res; 1990 Mar; 81(3):259-65. PubMed ID: 2112529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
    Sunkara PS; Rosenberger AL
    Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 283.